法规动态

FDA、EMA、TGA 及全球法规动态

#CILOSTAZOL ×

2026年9月3日•1 分钟阅读

FDA Approves Apotex CILOSTAZOL (ANDA077030)

FDA has approved Apotex's oral cilostazol tablets (50 mg and 100 mg) under ANDA 077030, adding a generic phosphodiesterase‑3 inhibitor to the market.

2026年8月30日•1 分钟阅读

FDA Approves CILOSTAZOL Tablets (ANDA077831)

FDA has approved Chartwell Rx's ANDA077831 for oral CILOSTAZOL tablets in 50 mg and 100 mg strengths, with labeling updates approved in 2016.